TMDX TransMedics Group, Inc.
TransMedics Group, Inc. (TMDX) is expected to report earnings on February 4, 2027, after the market close. The consensus earnings estimate is $0.41 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +15.5% since its last earnings release on November 5, 2026.
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About TransMedics Group, Inc.
TransMedics is the world's leader in portable extracorporeal warm perfusion and assessment of donor organs for transplantation.
Sector
Healthcare
Industry
Medical Appliances/Equipment
Held By 2 ETFs, by dollar flow
Charts powered in part by Lightweight Charts™ by TradingView.